The Bloodwise TAP CALiBRe feasibility study to assess the mechanism of action of idelalisib in B-cell receptor pathway inhibition in chronic lymphocytic leukaemia.
Authors
Munir, TRawstron, A
Brock, K
Munoz-Vicente, S
Bishop, R
Yates, F
Dalal, S
de Tute, R
Fox, C
McDonald, D
Fegan, C
Bloor, Adrian
Schuh, A
Hillmen, P
Affiliation
St James University Hospital, LeedsIssue Date
2018